First-in-man phase 1 study of TAS-114 in combination with S-1 in Japanese patients with advanced solid tumors

2016 ◽  
Vol 69 ◽  
pp. S120
Author(s):  
T. Doi ◽  
K. Yoh ◽  
K. Shitara ◽  
H. Takahashi ◽  
M. Ueno ◽  
...  
Keyword(s):  
Solid Tumors ◽  
Phase 1 ◽  
Japanese Patients ◽  
Advanced Solid Tumors ◽  
Phase 1 Study

Phase 1 study of the investigational, oral angiogenesis inhibitor motesanib in Japanese patients with advanced solid tumors

2010 ◽  
Vol 66 (5) ◽  
pp. 935-943 ◽  
Author(s):  
Yasuhito Fujisaka ◽  
Yasuhide Yamada ◽  
Noboru Yamamoto ◽  
Toshio Shimizu ◽  
Yutaka Fujiwara ◽  
...  
Keyword(s):  
Solid Tumors ◽  
Phase 1 ◽  
Angiogenesis Inhibitor ◽  
Japanese Patients ◽  
Advanced Solid Tumors ◽  
Phase 1 Study

scholarly journals A Phase 1 Study of Necitumumab (Anti-Egfr Monoclonal Antibody) in Japanese Patients with Advanced Solid Tumors

2014 ◽  
Vol 25 ◽  
pp. v70 ◽  
Author(s):  
Hiroshi Nokihara ◽  
Noboru Yamamoto ◽  
Yosuke Tamura ◽  
Yuko Tanabe ◽  
Kazunori Honda ◽  
...  
Keyword(s):  
Monoclonal Antibody ◽  
Solid Tumors ◽  
Phase 1 ◽  
Japanese Patients ◽  
Advanced Solid Tumors ◽  
Phase 1 Study

scholarly journals A phase 1 study of ramucirumab in Japanese patients with advanced solid tumors

2017 ◽  
Vol 47 (4) ◽  
pp. 298-305 ◽  
Author(s):  
Hiroshi Nokihara ◽  
Noboru Yamamoto ◽  
Yasuhide Yamada ◽  
Kazunori Honda ◽  
Hajime Asahina ◽  
...  
Keyword(s):  
Solid Tumors ◽  
Phase 1 ◽  
Japanese Patients ◽  
Advanced Solid Tumors ◽  
Phase 1 Study

scholarly journals Phase 1 Study of the Selective Akt Inhibitor MK-2206 in Japanese Patients with Advanced Solid Tumors

2012 ◽  
Vol 23 ◽  
pp. ix164
Author(s):  
Y. Tanabe ◽  
T. Doi ◽  
K. Tamura ◽  
K. Yonemori ◽  
M. Kodaira ◽  
...  
Keyword(s):  
Solid Tumors ◽  
Phase 1 ◽  
Japanese Patients ◽  
Advanced Solid Tumors ◽  
Akt Inhibitor ◽  
Phase 1 Study

Phase 1 study of galunisertib, a TGF-beta receptor I kinase inhibitor, in Japanese patients with advanced solid tumors

2015 ◽  
Vol 76 (6) ◽  
pp. 1143-1152 ◽  
Author(s):  
Yutaka Fujiwara ◽  
Hiroshi Nokihara ◽  
Yasuhide Yamada ◽  
Noboru Yamamoto ◽  
Kuniko Sunami ◽  
...  
Keyword(s):  
Solid Tumors ◽  
Kinase Inhibitor ◽  
Phase 1 ◽  
Japanese Patients ◽  
Advanced Solid Tumors ◽  
Tgf Beta ◽  
Phase 1 Study ◽  
Beta Receptor

scholarly journals Phase 1 study of trebananib (AMG 386), an angiogenesis targeting angiopoietin-1/2 antagonist, in Japanese patients with advanced solid tumors

2012 ◽  
Vol 71 (1) ◽  
pp. 227-235 ◽  
Author(s):  
Toshihiko Doi ◽  
Atsushi Ohtsu ◽  
Nozomu Fuse ◽  
Takayuki Yoshino ◽  
Makoto Tahara ◽  
...  
Keyword(s):  
Solid Tumors ◽  
Phase 1 ◽  
Japanese Patients ◽  
Advanced Solid Tumors ◽  
Phase 1 Study ◽  
Amg 386 ◽  
Angiopoietin 1

scholarly journals Phase 1 study of ombrabulin in combination with docetaxel and cisplatin in Japanese patients with advanced solid tumors

2018 ◽  
Vol 48 (4) ◽  
pp. 322-328 ◽  
Author(s):  
Makoto Nishio ◽  
Miyako Satouchi ◽  
Atsushi Horiike ◽  
Yoshitsugu Horio ◽  
Yoshinori Sunaga ◽  
...  
Keyword(s):  
Solid Tumors ◽  
Phase 1 ◽  
Japanese Patients ◽  
Advanced Solid Tumors ◽  
Phase 1 Study

scholarly journals First-in-human phase 1 study of novel dUTPase inhibitor TAS-114 in combination with S-1 in Japanese patients with advanced solid tumors

2018 ◽  
Vol 37 (3) ◽  
pp. 507-518 ◽  
Author(s):  
Toshihiko Doi ◽  
Kiyotaka Yoh ◽  
Kohei Shitara ◽  
Hideaki Takahashi ◽  
Makoto Ueno ◽  
...  
Keyword(s):  
Solid Tumors ◽  
Phase 1 ◽  
Japanese Patients ◽  
Advanced Solid Tumors ◽  
Phase 1 Study

scholarly journals Phase 1 study of pembrolizumab (MK-3475; anti-PD-1 monoclonal antibody) in Japanese patients with advanced solid tumors

2016 ◽  
Vol 34 (3) ◽  
pp. 347-354 ◽  
Author(s):  
Toshio Shimizu ◽  
Takashi Seto ◽  
Fumihiko Hirai ◽  
Mitsuhiro Takenoyama ◽  
Kaname Nosaki ◽  
...  
Keyword(s):  
Monoclonal Antibody ◽  
Solid Tumors ◽  
Phase 1 ◽  
Japanese Patients ◽  
Advanced Solid Tumors ◽  
Phase 1 Study
Sign in / Sign up

Export Citation Format

Share Document